Tecan Group AG (TCHBF)
TCHBF Stock Price Chart
Explore Tecan Group AG interactive price chart. Choose custom timeframes to analyze TCHBF price movements and trends.
TCHBF Company Profile
Discover essential business fundamentals and corporate details for Tecan Group AG (TCHBF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
1 Apr 2013
Employees
3.07K
Website
https://www.tecan.comCEO
Achim von Leoprechting
Description
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.
TCHBF Financial Timeline
Browse a chronological timeline of Tecan Group AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Mar 2026
Earnings released on 12 Aug 2025
EPS came in at $3.33 surpassing the estimated $3.16 by +5.38%, while revenue for the quarter reached $553.95M , beating expectations by +0.66%.
Dividend declared on 12 Mar 2025
A dividend of $1.83 per share was announced, adjusted to $3.75. The dividend was paid on 16 Apr 2025.
Earnings released on 10 Mar 2025
EPS came in at $3.89 falling short of the estimated $4.03 by -3.47%, while revenue for the quarter reached $514.34M , beating expectations by +1.53%.
Earnings released on 13 Aug 2024
EPS came in at $1.95 falling short of the estimated $4.94 by -60.53%, while revenue for the quarter reached $521.38M , missing expectations by -5.97%.
Dividend declared on 12 Mar 2024
A dividend of $3.29 per share was announced, adjusted to $3.75. The dividend was paid on 24 Apr 2024.
Earnings released on 27 Feb 2024
EPS came in at $7.18 surpassing the estimated $6.85 by +4.82%, while revenue for the quarter reached $622.78M , missing expectations by -1.61%.
Earnings released on 30 Jun 2023
EPS came in at $4.64 falling short of the estimated $6.24 by -25.64%, while revenue for the quarter reached $603.71M , beating expectations by +1.18%.
Dividend declared on 14 Mar 2023
A dividend of $3.24 per share was announced, adjusted to $3.62. The dividend was paid on 24 Apr 2023.
Earnings released on 31 Dec 2022
EPS came in at $4.67 falling short of the estimated $6.90 by -32.32%, while revenue for the quarter reached $605.77M , beating expectations by +1.72%.
Earnings released on 30 Jun 2022
EPS came in at $5.38 falling short of the estimated $5.67 by -5.11%, while revenue for the quarter reached $609.64M , beating expectations by +6.02%.
Dividend declared on 15 Mar 2022
A dividend of $1.48 per share was announced, adjusted to $3.50. The dividend was paid on 20 Apr 2022.
Earnings released on 31 Dec 2021
EPS came in at $5.40 falling short of the estimated $6.08 by -11.18%, while revenue for the quarter reached $517.60M , missing expectations by -7.86%.
Earnings released on 30 Jun 2021
EPS came in at $5.35 falling short of the estimated $6.55 by -18.32%, while revenue for the quarter reached $512.37M , beating expectations by +8.88%.
Dividend declared on 16 Mar 2021
A dividend of $2.49 per share was announced, adjusted to $2.87. The dividend was paid on 19 Apr 2021.
Earnings released on 31 Dec 2020
EPS came in at $4.87 , while revenue for the quarter reached $413.32M , missing expectations by -7.97%.
TCHBF Stock Performance
Access detailed TCHBF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.